766508-67-2 Usage
Uses
Used in Pharmaceutical Industry:
4-(3'-Carboxyphenyl)piperidine is used as a starting material or intermediate in the synthesis of pharmaceuticals for [application reason] its structural similarity to biologically active molecules, which allows for the development of new drugs to treat neurological disorders, manage pain, and address psychiatric illnesses.
Used in Drug Discovery and Development:
4-(3'-Carboxyphenyl)piperidine is used as a lead compound in drug discovery for [application reason] its potential to interact with various receptors and enzymes, which could lead to the identification of novel therapeutic agents.
Used in Chemical Research:
4-(3'-Carboxyphenyl)piperidine is used as a research compound in chemical studies for [application reason] understanding its interactions with biological targets and exploring its potential as a ligand for receptors and enzymes, contributing to the advancement of medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 766508-67-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,6,6,5,0 and 8 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 766508-67:
(8*7)+(7*6)+(6*6)+(5*5)+(4*0)+(3*8)+(2*6)+(1*7)=202
202 % 10 = 2
So 766508-67-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H15NO2/c14-12(15)11-3-1-2-10(8-11)9-4-6-13-7-5-9/h1-3,8-9,13H,4-7H2,(H,14,15)
766508-67-2Relevant articles and documents
Design and synthesis of a new class of malonyl-CoA decarboxylase inhibitors with anti-obesity and anti-diabetic activities
Tang, Haifeng,Yan, Yan,Feng, Zhe,De Jesus, Reynalda K.,Yang, Lihu,Levorse, Dorothy A.,Owens, Karen A.,Akiyama, Taro E.,Bergeron, Raynald,Castriota, Gino A.,Doebber, Thomas W.,Ellsworth, Kenneth P.,Lassman, Michael E.,Li, Cai,Wu, Margaret S.,Zhang, Bei B.,Chapman, Kevin T.,Mills, Sander G.,Berger, Joel P.,Pasternak, Alexander
scheme or table, p. 6088 - 6092 (2010/11/18)
A new series of thiazole-substituted 1,1,1,3,3,3-hexafluoro-2-propanols were prepared and evaluated as malonyl-CoA decarboxylase (MCD) inhibitors. Key analogs caused dose-dependent decreases in food intake and body weight in obese mice. Acute treatment with these compounds also led to a drop in elevated blood glucose in a murine model of type II diabetes.
